{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:58:41Z","timestamp":1791845921539,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11864-006-0014-9","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T18:16:29Z","timestamp":1183572989000},"page":"213-222","source":"Crossref","is-referenced-by-count":29,"title":["Management of marginal zone lymphomas"],"prefix":"10.1007","volume":"7","author":[{"given":"Catherine","family":"Thieblemont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2559.2002.01360.x","volume":"40","author":"B Maes","year":"2002","unstructured":"Maes B, De Wolf-Peeters C: Marginal zone cell lymphoma-an update on recent advances. Histopathology 2002, 40:117\u2013126.","journal-title":"Histopathology"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al.: A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994, 84:1361\u20131392.","journal-title":"Blood"},{"key":"14_CR3","volume-title":"World Health Organization Classification of Tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW: World Health Organization Classification of Tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001."},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","volume":"78","author":"SP Mulligan","year":"1991","unstructured":"Mulligan SP, Matutes E, Dearden C, Catovsky D: Splenic lymphoma with villous lymphocytes. Natural history and response to therapy in 50 cases. Br J Haematol 1991, 78:206\u2013209.","journal-title":"Br J Haematol"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","volume":"93","author":"X Troussard","year":"1996","unstructured":"Troussard X, Valensi F, Duchayne E, et al.: Splenic lym-phoma with villous lymphocytes: clinical presenta-tion, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 1996, 93:731\u2013736.","journal-title":"Br J Haematol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","volume":"4","author":"C Thieblemont","year":"2003","unstructured":"Thieblemont C, Felman P, Callet-Bauchu E, et al.: Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003, 4:95\u2013103.","journal-title":"Lancet Oncol"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","volume":"17","author":"B Nathwani","year":"1999","unstructured":"Nathwani B, Anderson J, Armitage J, et al.: Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999, 17:2486\u20132492.","journal-title":"J Clin Oncol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","volume":"95","author":"F Berger","year":"2000","unstructured":"Berger F, Felman P, Thieblemont C, et al.: Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000, 95:1950\u20131956.","journal-title":"Blood"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2005.03.083","volume":"128","author":"P Farinha","year":"2005","unstructured":"Farinha P, Gascoyne R: Helicobacter pylori and MALT lymphoma. Gastroenterology 2005, 128:1579\u20131605.","journal-title":"Gastroenterology"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","volume":"24","author":"L Cerroni","year":"1997","unstructured":"Cerroni L, Zochling N, Putz B, Kerl H: Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997, 24:457\u2013461.","journal-title":"J Cutan Pathol"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit M, Abachin E, Martin A, et al.: Immunoprolifera-tive small intestinal disease associated with Campylo-bacter jejuni. N Engl J Med 2004, 350:239\u2013248.","journal-title":"N Engl J Med"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","volume":"96","author":"A Ferreri","year":"2004","unstructured":"Ferreri A, Guidoboni M, Ponzoni M, et al.: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004, 96:586\u2013594.","journal-title":"J Natl Cancer Inst"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, et al.: Nongastric mar-ginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003, 101: 2489\u20132495.","journal-title":"Blood"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","volume":"100","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Paulli M, Boveri E, et al.: Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004, 100:107\u2013115.","journal-title":"Cancer"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/sj.leu.2400878","volume":"11","author":"I Bates","year":"1997","unstructured":"Bates I, Bedu-Addo G: Chronic malaria and splenic lymphoma: clues to understanding lymphoma evolu-tion. Leukemia 1997, 11 : 2162\u20132167.","journal-title":"Leukemia"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E, et al.: Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997, 26:527\u2013537.","journal-title":"Leuk Lymphoma"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","volume":"15","author":"C Thieblemont","year":"1997","unstructured":"Thieblemont C, Bastion Y, Berger F, et al.: Mucosa-asso-ciated lymphoid tissue gastrointestinal and non-gastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997, 15:1624\u20131630.","journal-title":"J Clin Oncol"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"802d","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, et al.: Mucosa-associated lymphoid tissue lymphoma is a dissemi-nated disease in one third of 158 patients analyzed. Blood 2000, 95:802d-806d.","journal-title":"Blood"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","volume":"52","author":"C Copie-Bergman","year":"2003","unstructured":"Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al.: Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003, 52:1656.","journal-title":"Gut"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"15","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, et al.: Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003, 15:2741\u20132745.","journal-title":"Blood"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"A Wotherspoon","year":"1993","unstructured":"Wotherspoon A, Doglioni C, Diss T, et al.: Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342:575\u2013577. This is the first report of a lymphoma regression obtained by antibiotics. This key reference leads to build the \u201cMALT concept.\u2253","journal-title":"Lancet"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T Wundisch","year":"2005","unstructured":"Wundisch T, Thiede C, Morgner A, et al.: Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005, 23:8018\u20138024.","journal-title":"J Clin Oncol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","volume":"31","author":"E Roggero","year":"2000","unstructured":"Roggero E, Zucca E, Mainetti C, et al.: Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000, 31: 263\u2013268.","journal-title":"Hum Pathol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V99.7.2541","volume":"99","author":"F Bertoni","year":"2002","unstructured":"Bertoni F, Conconi A, Capella C, et al.: Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002, 99:2541\u20132544","journal-title":"Blood"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0360-3016(01)01549-8","volume":"50","author":"R Tsang","year":"2001","unstructured":"Tsang R, Gospodarowicz M, Pintilie M, et al.: Stage I and II MALT lymphoma: results of treatment with radio-therapy. Int J Radiat Oncol Biol Phys 2001, 50:1258\u20131264.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"N Schechter","year":"1998","unstructured":"Schechter N, Portlock C, Yahalom J: Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998, 16:1916\u20131921.","journal-title":"J Clin Oncol"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","volume":"13","author":"P Hammel","year":"1995","unstructured":"Hammel P, Haioun C, Chaumette M, et al.: Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995, 13:2524\u20132529.","journal-title":"J Clin Oncol"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri A, et al.: Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helico-bacter pylori therapy. J Clin Oncol 2005, 23:1979\u20131983.","journal-title":"J Clin Oncol"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","volume":"102","author":"T Radaszkiewicz","year":"1992","unstructured":"Radaszkiewicz T, Dragosics B, Bauer P: Gastrointestinal malignant lymphomas of the mucosa-associated lym-phoid tissue: factors relevant to prognosis. Gastroenter-ology 1992, 102: 1628\u20131638.","journal-title":"Gastroenter-ology"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/oxfordjournals.annonc.a059184","volume":"6","author":"C Montalban","year":"1995","unstructured":"Montalban C, Castrillo J, Abraira V, et al.: Gastric B-cell mucosa-associated lymphoid tissue (MALT) lym-phoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995, 6:355\u2013362.","journal-title":"Ann Oncol"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9440(10)65012-2","volume":"156","author":"M Baens","year":"2000","unstructured":"Baens M, Maes B, Steyls A, et al.: The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000, 156:1433\u20131439.","journal-title":"Am J Pathol"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al.: Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradi-cation therapy. Lancet 2001, 357:39\u201340.","journal-title":"Lancet"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","volume":"23","author":"M Levy","year":"2005","unstructured":"Levy M, Copie-Bergman C, Gameiro C, et al.: Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005, 23:5061\u20135066.","journal-title":"J Clin Oncol"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","volume":"3","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Felman P, Berger F, et al.: Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 2002, 3:41\u201347.","journal-title":"Clin Lymphoma"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20137","volume":"110","author":"R Talamini","year":"2004","unstructured":"Talamini R, Montella M, Crovatto M, et al.: Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004, 110 : 380\u2013385.","journal-title":"Int J Cancer"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"11","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki J, et al.: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002, 11 : 89\u201394. The authors describe the first series of patients treated with an antiviral therapy, inducing a lymphoma regression.","journal-title":"N Engl J Med"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"J Chacon","year":"2002","unstructured":"Chacon J, Mollejo M, Munoz E, et al.: Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 2002, 100:1648\u20131654.","journal-title":"Blood"},{"key":"14_CR38","first-page":"148","volume":"36","author":"D Catovsky","year":"1999","unstructured":"Catovsky D, Matutes E: Splenic lymphoma with circu-lating villous lymphocytes\/splenic marginal-zone lymphoma. Semin Hematol 1999, 36:148\u2013154.","journal-title":"Semin Hematol"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","volume":"91","author":"V Franco","year":"2001","unstructured":"Franco V, Florena A, Stella M, et al.: Splenectomy influ-ences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer 2001, 91: 294\u2013301","journal-title":"Cancer"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","volume":"14","author":"F Lefrere","year":"2000","unstructured":"Lefrere F, Hermine O, Belanger C, et al.: Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 2000, 14:573\u2013575.","journal-title":"Leukemia"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","volume":"40","author":"F Lefrere","year":"2000","unstructured":"Lefrere F, Hermine O, Francois S, et al.: Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes. Leuk Lymphoma 2000, 40:113\u201311 7.","journal-title":"Leuk Lymphoma"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","volume":"25","author":"FI Camacho","year":"2001","unstructured":"Camacho FI, Mollejo M, Mateo MS, et al.: Progression to large B-cell lymphoma in splenic marginal zone lymphoma--a description of a series of 12 cases. Am J Surg Pathol 2001, 25:1268\u20131276.","journal-title":"Am J Surg Pathol"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","volume":"89","author":"A Neubauer","year":"1997","unstructured":"Neubauer A, Thiede C, Morgner A, et al.: Cure of Helico-bacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997, 89:1350\u20131355.","journal-title":"J Natl Cancer Inst"},{"key":"14_CR44","unstructured":"Berger F: The different entities and diagnostic problems. Educational Program of the European Hematology Association Meeting. Birmingham, UK, June 25\u201328, 2000."},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02780533","volume":"17","author":"L Koh","year":"2000","unstructured":"Koh L, Lim L, Thng C: Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma. Med Oncol 2000, 17:225\u2013228.","journal-title":"Med Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-006-0014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-006-0014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-006-0014-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T01:25:03Z","timestamp":1587691503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-006-0014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11864-006-0014-9","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}